Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (151-160 of 298) with videos related to

Pageof 30
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 12, 2019
Engrailed-1 induces long-lasting behavior benefit in an experimental Parkinson primate modelNitza Thomasson, Elsa Pioli, Claire Friedel, et al.
NPJ Parkinson'S Disease|July 26, 2023
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson's disease primate modelIbrahim Kaya, Anna Nilsson, Dominika Luptáková, et al.
Neurobiology of Aging|August 13, 2021
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairmentMorgane Darricau, Marie-Hélène Canron, Marion Bosc, et al.
The Journal of Comparative Neurology|November 22, 2011
Localization of endogenous morphine-like compounds in the mouse spinal cordAlexis Laux, François Delalande, Jinane Mouheiche, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 9, 2017
Alterations in Functional Cortical Hierarchy in Hemiparkinsonian RatsBorbála Nóra Jávor-Duray, Martin Vinck, Marcel van der Roest, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2004
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's diseaseMichael P Hill, Paula Ravenscroft, Erwan Bezard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2017
Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophyFares Bassil, Paul A Guerin, Nathalie Dutheil, et al.
Scientific Reports|January 17, 2014
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatumGregory Porras, Philippe De Deurwaerdere, Qin Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2014
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque modelErwan Bezard, Elsa Y Pioli, Qin Li, et al.
Cells|November 3, 2020
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System AtrophyFlorent Laferrière, Xin He, Federica Zinghirino, et al.
Pageof 30

Showing results (151-160 of 298) with videos related to

Sort By:
Pageof 30
Movement Disorders : Official Journal of the Movement Disorder Society|May 12, 2019
Engrailed-1 induces long-lasting behavior benefit in an experimental Parkinson primate modelNitza Thomasson, Elsa Pioli, Claire Friedel, et al.
NPJ Parkinson'S Disease|July 26, 2023
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson's disease primate modelIbrahim Kaya, Anna Nilsson, Dominika Luptáková, et al.
Neurobiology of Aging|August 13, 2021
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairmentMorgane Darricau, Marie-Hélène Canron, Marion Bosc, et al.
The Journal of Comparative Neurology|November 22, 2011
Localization of endogenous morphine-like compounds in the mouse spinal cordAlexis Laux, François Delalande, Jinane Mouheiche, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 9, 2017
Alterations in Functional Cortical Hierarchy in Hemiparkinsonian RatsBorbála Nóra Jávor-Duray, Martin Vinck, Marcel van der Roest, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2004
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's diseaseMichael P Hill, Paula Ravenscroft, Erwan Bezard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 31, 2017
Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophyFares Bassil, Paul A Guerin, Nathalie Dutheil, et al.
Scientific Reports|January 17, 2014
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatumGregory Porras, Philippe De Deurwaerdere, Qin Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2014
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque modelErwan Bezard, Elsa Y Pioli, Qin Li, et al.
Cells|November 3, 2020
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System AtrophyFlorent Laferrière, Xin He, Federica Zinghirino, et al.
Pageof 30